Letty W. Kwok
Boston University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Letty W. Kwok.
Cell Stem Cell | 2012
Tyler A. Longmire; Laertis Ikonomou; Finn Hawkins; Constantina Christodoulou; Yuxia Cao; Jyh-Chang Jean; Letty W. Kwok; Hongmei Mou; Jayaraj Rajagopal; Steven S. Shen; Anne A. Dowton; Maria Serra; Daniel J. Weiss; Michael D. Green; Hans-Willem Snoeck; Maria I. Ramirez; Darrell N. Kotton
Two populations of Nkx2-1(+) progenitors in the developing foregut endoderm give rise to the entire postnatal lung and thyroid epithelium, but little is known about these cells because they are difficult to isolate in a pure form. We demonstrate here the purification and directed differentiation of primordial lung and thyroid progenitors derived from mouse embryonic stem cells (ESCs). Inhibition of TGFβ and BMP signaling, followed by combinatorial stimulation of BMP and FGF signaling, can specify these cells efficiently from definitive endodermal precursors. When derived using Nkx2-1(GFP) knockin reporter ESCs, these progenitors can be purified for expansion in culture and have a transcriptome that overlaps with developing lung epithelium. Upon induction, they can express a broad repertoire of markers indicative of lung and thyroid lineages and can recellularize a 3D lung tissue scaffold. Thus, we have derived a pure population of progenitors able to recapitulate the developmental milestones of lung/thyroid development.
Journal of Clinical Investigation | 2010
Andrew A. Wilson; George J. Murphy; Hiroshi Hamakawa; Letty W. Kwok; Sreedevi Srinivasan; Avi-Hai Hovav; Richard C. Mulligan; Salomon Amar; Béla Suki; Darrell N. Kotton
Directed gene transfer into specific cell lineages in vivo is an attractive approach for both modulating gene expression and correcting inherited mutations such as emphysema caused by human alpha1 antitrypsin (hAAT) deficiency. However, somatic tissues are mainly comprised of heterogeneous, differentiated cell lineages that can be short lived and difficult to specifically transfect. Here, we describe an intratracheally instilled lentiviral system able to deliver genes selectively to as many as 70% of alveolar macrophages (AMs) in the mouse lung. Following a single in vivo lentiviral transduction, genetically tagged AMs persisted in lung alveoli and expressed transferred genes for the lifetime of the adult mouse. A prolonged macrophage lifespan, rather than precursor cell proliferation, accounted for the surprisingly sustained presence of transduced AMs. We utilized this long-lived population to achieve localized secretion of therapeutic levels of hAAT protein in lung epithelial lining fluid. In an established mouse model of emphysema, lentivirally delivered hAAT ameliorated the progression of emphysema, as evidenced by attenuation of increased lung compliance and alveolar size. After 24 weeks of sustained gene expression, no humoral or cellular immune responses to hAAT protein were detected. Our results challenge the dogma that AMs are short lived and suggest that these differentiated cells may be a possible target cell population for in vivo gene therapy applications, including the sustained correction of hAAT deficiency.
Molecular Therapy | 2013
Andrew A. Wilson; Letty W. Kwok; Emily L. Porter; Julie G. Payne; Gregory S McElroy; Sarah J. Ohle; Sara Greenhill; Matthew T. Blahna; Kazuko Yamamoto; Jyh C. Jean; Joseph P. Mizgerd; Darrell N. Kotton
Although RNA interference (RNAi) has become a ubiquitous laboratory tool since its discovery 12 years ago, in vivo delivery to selected cell types remains a major technical challenge. Here, we report the use of lentiviral vectors for long-term in vivo delivery of RNAi selectively to resident alveolar macrophages (AMs), key immune effector cells in the lung. We demonstrate the therapeutic potential of this approach by RNAi-based downregulation of p65 (RelA), a component of the pro-inflammatory transcriptional regulator, nuclear factor κB (NF-κB) and a key participant in lung disease pathogenesis. In vivo RNAi delivery results in decreased induction of NF-κB and downstream neutrophilic chemokines in transduced AMs as well as attenuated lung neutrophilia following stimulation with lipopolysaccharide (LPS). Through concurrent delivery of a novel lentiviral reporter vector (lenti-NF-κB-luc-GFP) we track in vivo expression of NF-κB target genes in real time, a critical step towards extending RNAi-based therapy to longstanding lung diseases. Application of this system reveals that resident AMs persist in the airspaces of mice following the resolution of LPS-induced inflammation, thus allowing these localized cells to be used as effective vehicles for prolonged RNAi delivery in disease settings.
Stem cell reports | 2017
Keri Dame; Steven Cincotta; Alex H. Lang; Reeti M. Sanghrajka; Liye Zhang; Jinyoung Choi; Letty W. Kwok; Talitha Wilson; Maciej M. Kańduła; Stefano Monti; Anthony N. Hollenberg; Pankaj Mehta; Darrell N. Kotton; Laertis Ikonomou
Summary The clinical importance of anterior foregut endoderm (AFE) derivatives, such as thyrocytes, has led to intense research efforts for their derivation through directed differentiation of pluripotent stem cells (PSCs). Here, we identify transient overexpression of the transcription factor (TF) NKX2-1 as a powerful inductive signal for the robust derivation of thyrocyte-like cells from mouse PSC-derived AFE. This effect is highly developmental stage specific and dependent on FOXA2 expression levels and precise modulation of BMP and FGF signaling. The majority of the resulting cells express thyroid TFs (Nkx2-1, Pax8, Foxe1, Hhex) and thyroid hormone synthesis-related genes (Tg, Tpo, Nis, Iyd) at levels similar to adult mouse thyroid and give rise to functional follicle-like epithelial structures in Matrigel culture. Our findings demonstrate that NKX2-1 overexpression converts AFE to thyroid epithelium in a developmental time-sensitive manner and suggest a general methodology for manipulation of cell-fate decisions of developmental intermediates.
Cell Cycle | 2010
Junjie Wu; Jun Qian; Letty W. Kwok; Feng Cheng; Peijun Liu; Catalina Perdomo; Darrell N. Kotton; Cyrus Vaziri; Christina Anderlind; Avrum Spira; Wellington V. Cardoso; Jining Lü
American Journal of Respiratory Cell and Molecular Biology | 2008
Andrew A. Wilson; Letty W. Kwok; Avi-Hai Hovav; Sarah J. Ohle; Frédéric F. Little; Alan Fine; Darrell N. Kotton
american thoracic society international conference | 2012
Laertis Ikonomou; Jyh-Chang Jean; Letty W. Kwok; Tyler A. Longmire; Darrell N. Kotton
american thoracic society international conference | 2011
Andrew A. Wilson; Letty W. Kwok; Emily L. Porter; Darrell N. Kotton
american thoracic society international conference | 2010
Andrew A. Wilson; George J. Murphy; Hiroshi Hamakawa; Letty W. Kwok; Sreedevi Srinivasan; Avi-Hai Hovav; Richard C. Mulligan; Salomon Amar; Béla Suki; Darrell N. Kotton
american thoracic society international conference | 2009
Andrew A. Wilson; George J. Murphy; Hiroshi Hamakawa; Letty W. Kwok; Sreedevi Srinivasan; Avi-Hai Hovav; Richard C. Mulligan; Salomon Amar; Béla Suki; Darrell N. Kotton